青藤碱治疗类风湿性关节炎抑制骨破坏的研究进展

丁从珠; 汪悦; 姚瑶; 方芸

青藤碱治疗类风湿性关节炎抑制骨破坏的研究进展

丁从珠^1,,
汪悦²,
姚瑶¹,
方芸¹

1.
南京中医药大学中西医结合鼓楼临床医学院，江苏南京 210008
2.
南京中医药大学第一临床医学院，江苏南京 210046

计量
- 文章访问数: 892
- HTML全文浏览量: 2
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2010-06-12
- 修回日期: 2010-08-24
- 刊出日期: 2011-01-10

摘要

摘要: 类风湿性关节炎(rheumatoid arthritis，RA)骨质侵蚀与关节破坏是近年来研究的热点。破骨细胞是导致关节侵蚀的主要细胞。将近几年青藤碱( sinomenine，SIN)在类风湿性关节炎骨破坏的调控机制予以综述，以期进一步研究SIN对RA破骨细胞的作用机制。
- 类风湿性关节炎 /
- 青藤碱 /
- 骨破坏

HTML全文

参考文献(46)

[1]	Kotake S;Udagawa N;Takahashi N,IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,Journal of Clinical Investigation ,1999, 103(09).
[2]	Li P;Schwarz EM;O\'Keefe RJ,RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis,Journal of Bone and Mineral Research,2004(02).
[3]	Sato K;Suematsu A;Okamoto K Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction [J] 2006(12) doi: 10.1084/jem.20061775
[4]	Redlich K;Hayer S;Ricci R,Osteoclasts are essential for TNF-amediated joint destruction,Journal of Clinical Investigation,2002.
[5]	Takayanagi H;Ogasawara K;Hida S,T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ,Nature,2000.
[6]	金晓琨,李卫东,滕慧玲,青藤碱对核转录因子κB及其抑制因子IκB的影响,中国药理学通报,2004(07).
[7]	Horwood NJ;Kartsogiannis V;Quinn JM Activated T lymphocytes support osteoclast formation in vitro [J] 1999(1) doi: 10.1006/bbrc.1999.1623
[8]	王勇;方勇飞;周新,青藤碱对佐剂性关节炎大鼠腹腔巨噬细胞表达细胞因子的影响,中华风湿病学杂志,2003(07).
[9]	蒋明;David YU;林孝义,中华风湿病学,北京:华夏出版社,2004.
[10]	蒋明;David YU;林孝义,中华风湿病学,北京:华夏出版社,2004.
[11]	王勇;方勇飞;周新.青藤碱对佐剂性关节炎大鼠腹腔巨噬细胞表达细胞因子的影响[J].中华风湿病学杂志,2003(07)
[12]	Horwood NJ;Kartsogiannis V;Quinn JM,Activated T lymphocytes support osteoclast formation in vitro,Biochemical and Biophysical Research Communications,1999(1).
[13]	金晓琨,李卫东,滕慧玲.青藤碱对核转录因子κB及其抑制因子IκB的影响[J].中国药理学通报,2004(07)
[14]	Takayanagi H;Ogasawara K;Hida S,T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ,Nature,2000.
[15]	Cohen SB;Valen P;Ritchlin C,RANKL inhibition with denosumab reduces progression of bone erosions in patients with rheumatoid arthritis:month 6 MRI results,Arthritis and Rheumatism,2006(Suppl 9).
[16]	Sato K;Suematsu A;Okamoto K,Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction,Journal of Experimental Medicine,2006(12).
[17]	Mcclung MR;Lewiecki EM;Cohen SB Denosumab in postmenopausal women with low bone mineral density [J] 2006(8) doi: 10.1056/NEJMoa044459
[18]	Kotake S;Udagawa N;Takahashi N,IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,Journal of Clinical Investigation,1999.
[19]	Takayanagi H;Kim S;Taniguchi T,Signaling crosstalk between RANKL and interferons in osteoclast differentiation,Arthritis Research,2002(04).
[20]	Acosta-Rodriguez EV;Napolitani G;Lanzavecchia A,Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells,Nature Immunology,2007.
[21]	高永翔;龚立;田艳勋.青藤碱对小鼠骨髓树突状细胞免疫功能的影响[J].成都中医药大学学报,2005(03)
[22]	李晓娟,王培训,刘良,青藤碱对T淋巴细胞活化及Th1类细胞内细胞因子表达的影响,中国免疫学杂志,2004(04).
[23]	王勇;钟兵;方勇飞.青藤碱对类风湿关节炎患者炎性细胞因子及抗环瓜氨酸肽抗体的影响[J].第三军医大学学报,2005(15)
[24]	刘继红,李卫东,滕慧玲,青藤碱治疗类风湿性关节炎免疫作用和机制,药学学报,2005(02).
[25]	Nakamura I;Kadono Y;Takayanagi H,IL-1 regulates cytoskeletal organization steoclasts via TNF receptor-associated factor 6/c-Src complex,Journal of Immunology,2002.
[26]	Scott DL;Kingsley GH,Tumor necrosis factor inhibitors for rheumatoid arthritis,New England Journal of Medicine,2006.
[27]	Diarra D;Stolina M;Polzer K,Dickkopf-1 is a master regulator of joint remodeling,Nature Medicine ,2007, 13.
[28]	Boyle WJ;Simonet WS;Lacey DL,Osteoclast differentiation and activation,Nature,2003(6937).
[29]	Zhang Q;Badell IR;Schwarz EM,Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2,Arthritis and Rheumatism,2005.
[30]	Fuller K;Murphy C;Kirstein B,TNFalpha potently activates osteoclasts,through a direct action independent of and strongly synergistic with RANKL,Endocrinology,2002.
[31]	Fuller K;Murphy C;Kirstein B,TNF alpha potently activates osteoclasts,through a direct action independent of and strongly synergistic with RANKL,Endocrinology ,2002, 143(03).
[32]	Zhang Q;Badell IR;Schwarz EM,Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2,Arthritis and Rheumatism,2005.
[33]	Boyle WJ. ；Simonet WS. ；Lacey DL.,Osteoclast differentiation and activation [Review],Nature ,2003, 423(6937).
[34]	Diarra D;Stolina M;Polzer K,Dickkopf-1 is a master regulator of joint remodeling,Nature Medicine,2007.
[35]	Scott DL;Kingsley GH,Tumor necrosis factor inhibitors for rheumatoid arthritis,New England Journal of Medicine ,2006, 355(07).
[36]	Nakamura I;Kadono Y;Takayanagi H,IL-1 regulates cytoskeletal organization steoclasts via TNF receptor-associated factor 6/c-Src complex,Journal of Immunology,2002.
[37]	刘继红,李卫东,滕慧玲.青藤碱治疗类风湿性关节炎免疫作用和机制[J].药学学报,2005(02)
[38]	王勇;钟兵;方勇飞,青藤碱对类风湿关节炎患者炎性细胞因子及抗环瓜氨酸肽抗体的影响,第三军医大学学报,2005(15).
[39]	李晓娟,王培训,刘良.青藤碱对T淋巴细胞活化及Th1类细胞内细胞因子表达的影响[J].中国免疫学杂志,2004(04)
[40]	高永翔;龚立;田艳勋,青藤碱对小鼠骨髓树突状细胞免疫功能的影响,成都中医药大学学报,2005(03).
[41]	Acosta-Rodriguez EV;Napolitani G;Lanzavecchia A,Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells,Nature Immunology,2007.
[42]	Takayanagi H;Kim S;Taniguchi T,Signaling crosstalk between RANKL and interferons in osteoclast differentiation,Arthritis Research,2002(04).
[43]	Redlich K;Hayer S;Ricci R,Osteoclasts are essential for TNF-amediated joint destruction,Journal of Clinical Investigation,2002.
[44]	Mcclung MR;Lewiecki EM;Cohen SB,Denosumab in postmenopausal women with low bone mineral density,New England Journal of Medicine,2006(8).
[45]	Li P ；Schwarz EM ；O\'Keefe RJ ；Ma L ；Boyce BF ；Xing L,RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.,Journal of Bone and Mineral Research ,2004, 19(2).
[46]	Cohen SB;Valen P;Ritchlin C,RANKL inhibition with denosumab reduces progression of bone erosions in patients with rheumatoid arthritis:month 6 MRI results,Arthritis and Rheumatism,2006(Suppl 9).